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Abstract. 
Rapid diagnostic tests (RDTs) are widely used for malaria diagnosis, but lack of quality control at point of care 
restricts trust in test results. Prototype positive control wells (PCW) containing recombinant malaria antigens 
have been developed to identify poor-quality RDT lots. This study assessed community and facility health 
workers’ (HW) ability to use PCWs to detect degraded RDTs, the impact of PCW availability on RDT use and 
prescribing, and preferred strategies for implementation in Lao People’s Democratic Republic (Laos) and 
Uganda. A total of 557 HWs participated in Laos (267) and Uganda (290). After training, most (88% to  99%) 
participants correctly performed the six key individual PCW steps; performance was generally maintained 
during the 6-month study period. Nearly all (97%) reported a correct action based on PCW use at routine work 
sites. In Uganda, where data for 127,775 individual patients were available, PCW introduction in health 
facilities was followed by a decrease in antimalarial prescribing for RDT-negative patients  5 years of age 
(4.7–1.9%); among community-based HWs, the decrease was 12.2% (P < 0.05) for all patients. Qualitative data 
revealed PCWs as a way to confirm RDT quality and restore confidence in RDT results. HWs in malaria-
endemic areas are able to use prototype PCWs for quality control of malaria RDTs. PCW availability can 
improve HWs’ confidence in RDT results, and benefit malaria diagnostic programs. Lessons learned from this 
study may be valuable for introduction of other point-of-care diagnostic and quality-control tools. Future work 
should evaluate longer term impacts of PCWs on patient management. 
INTRODUCTION 
Rapid diagnostic tests (RDTs) are now widely used for malaria diagnosis, consistent with 
World Health Organization (WHO) recommendations for areas where good-quality malaria 
microscopy is not available, including peripheral health facilities and community-based fever 
management programs.
1,2
 The need for stable, high-performing RDTs, especially under 
transport and storage conditions typical in malaria-endemic regions, has received 
considerable attention.
3–5
 RDT lot-to-lot variation and susceptibility to deterioration upon 
exposure to high temperatures and humidity in supply chains have been documented.
6,7
 In 
addition, some reports attribute health workers’ poor adherence to RDT results at least in part 
to lack of confidence in test results.
8,9
 To maintain confidence in RDTs and optimize their 
utility, the tests must demonstrate consistently reliable results. However, RDT quality 
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control, after field deployment, is currently difficult to implement in routine health-care 
contexts.
10–12
 
A global program supports quality assurance activities for malaria RDTs through 
independent laboratory-based assessment of commercially available products manufactured 
under ISO13485, lot verification of procured RDTs, and provision of training materials.
13
 
Positive control wells (PCWs) have been proposed as point-of-care quality-control tools, as a 
third component of a tiered quality assurance program.
14–17
 Prototype PCWs have been 
developed as single-use plastic wells containing small amounts of recombinant malaria 
parasite antigens targeted by commercially available RDTs. When reconstituted with water 
and applied to a good-quality RDT, the antigen solution produces a positive reaction on the 
RDT. PCWs can therefore be used to test stocks of RDTs stored and used at health facilities, 
to ensure their validity. PCWs may also be used to monitor RDT quality along the supply 
chain. 
The study described here is part of a step-wise approach to collect evidence to guide 
rational implementation strategies for PCWs. The present study was designed to determine 
whether health workers in malaria-endemic settings can use PCWs correctly to detect RDTs 
with inadequate sensitivity after a half-day training, to assess the impact of PCW availability 
on RDT use, and to gather information on health workers’ perceptions of PCWs and 
preferred strategies for routine use in public health-care sectors. 
METHODS 
Ethics and protocol. 
All participating health workers provided written informed consent. Before participant 
recruitment, the study protocol was approved by the National Ethics Committee for Health 
Research, Lao People’s Democratic Republic (Laos) (NECHR 009/2012); Oxford Tropical 
Research Ethics Committee of the University of Oxford, United Kingdom (1000-13); Vector 
Control Division Ethical Committee of the Uganda Ministry of Health (VCD-IRC/038); 
Uganda National Council for Science and Technology (HS 1271); and Research Ethics 
Review Committee of the World Health Organization (protocol ID RPC545). 
Study sites and setting. 
The study was conducted from March to October 2013 in Salavan Province, southern 
Laos, and in Kiboga District, west-central Uganda. Study area selection criteria were malaria 
RDTs meeting WHO procurement criteria
18
 already in routine use in clinical care according 
to plans/programs approved by the national malaria control authorities, representative sites in 
Africa and Asia, and local collaborators experienced in the conduct of operational research on 
malaria diagnosis. 
Malaria transmission in Salavan Province is highly seasonal, typically beginning around 
June and peaking during and after the annual rainy season (Lao Center of Malariology, 
Parasitology and Entomology [CMPE], unpublished data). Malaria transmission in Kiboga 
District is moderately high year round (proportion of malaria blood slides positive in fever 
cases was 40–60% [Uganda Ministry of Health, unpublished data]). Before the study started, 
65–95% of fever patients were RDT negative in southern Laos, depending on season, 
whereas 40–60% of fever cases were RDT negative in midwestern Uganda. The study was 
conducted at government-sponsored health facilities and at community or village health 
volunteers’ work stations where RDTs are used in routine patient care. 
In addition, to assess the impact of PCW availability on RDT use, in each country, routine 
clinical data from a neighboring “control” area with similar climate, malaria epidemiology, 
health-care infrastructure, and RDT access but without PCWs (Sekong Province in Laos; 
Kyankwanzi District in Uganda) were obtained as aggregate summaries from the Ministry of 
Health (Laos) or from individual health facility and community worker logbooks (Uganda). 
RDTs used in this study were provided through routine procurement and distribution 
mechanisms in each country. In Laos, RDTs are provided to government health facilities and 
village health volunteers by CMPE, Lao Ministry of Health. The RDTs in use at the time of 
this study were SD Bioline Malaria Antigen Pf/Pv (catalogue no. 05FK80, lot 082171). In 
Uganda, RDTs were provided in the study area by a project led by the Malaria Consortium. 
The RDTs in use at the time of this study were SD Bioline Malaria Antigen Pf (catalogue no. 
05FK50, lot 082140). Before study activities began, RDTs from each study area passed lot 
testing at WHO and Foundation for Innovative New Diagnostics (WHO-FIND)–recognized 
lot testing laboratories.
19
 
Study population. 
Basic health care in the study areas is provided by staff of health facilities (“clinic staff” 
in this report), typically nursing and clinical staff with < 2–3 years of formal training; and by 
village or community health volunteers (“community workers”), literate or semiliterate 
volunteers with a few weeks’ training who work at or near their own home. The term “health 
worker” is used here to include both clinic staff and community workers. Within the study 
areas, health workers were invited to participate if their work place met these selection 
criteria: established use of RDTs in routine clinical work as the only parasite-based malaria 
diagnostic method (i.e., no microscopy capacity); at least five patients seen per month; and 
availability of records or logbook with data on RDT use, patient diagnoses, and treatments. 
Sample size. 
A sample size of approximately 300 health workers in each of the two study areas was 
targeted to participate and receive PCWs. The goal was to include a representative sample of 
health workers who use malaria RDTs in routine practice, with recruitment of approximately 
225 community workers in each country and the remainder being clinic staff. The target 
sample size represented approximately 3–5% of the community workers using RDTs in each 
country. 
Prototype PCW. 
The prototype PCW used was developed by FIND, Geneva, Switzerland, in partnership 
with ReaMetrix Inc., Bangalore, India. The product specifications of the PCW were single-
use, disposable, free-standing individual tube containing dried recombinant antigens, 
synthetic variants of the malaria parasite antigens targeted by commercially available RDTs, 
that is, histidine-rich protein 2, parasite lactate dehydrogenase, and aldolase (Figure 1). The 
PCW contained a sufficient concentration of each antigen to produce a test line on a well-
performing RDT, whereas failing to produce a line on an RDT that has deteriorated to a point 
unreliable for detection of clinically significant parasitemia (200 parasites/L).20 
To perform a PCW, antigens were reconstituted by adding 100 L of water (e.g., 
handwashing water) to the tube and stirring for 2 minutes using a squeezable pipette 
packaged with the PCW (see pictorial guide, Supplemental online material). The desired 
amount of PCW solution, that is, 5 L, was placed in the RDT sample well using the transfer 
device packaged with the RDT, and RDT buffer was added. The wicking speed along the 
nitrocellulose strip was similar to lysed blood and the test results were read according to RDT 
instructions. PCWs were stored in their original packaging at ambient temperature at the local 
offices/laboratories of collaborating research organizations in each country before study 
activities began, and at health worker work sites and homes during the study. 
PCW training and study initiation. 
All training and data collection tools are in the Supplemental online material. An initial 1-
week pilot assessment preceded the study, during which a pictorial guide (job aid) for PCW 
interpretation was developed for use in both Uganda and Laos. PCWs were introduced to 
participating health workers with a standardized half-day training package presented by 
members of the study team, who were individuals with laboratory and/or clinical background 
and with prior experience in clinical malaria research and/or program implementation. 
Trainings were typically held for groups of 12–20 health workers at a central point in each 
subregion within the study areas. No training in RDT use or fever case management was 
provided as part of this study. 
After the training and initial assessment, PCWs were given to each participating health 
worker, along with forms for recording PCW use. Health workers were not given specific 
guidance on when or how frequently to use PCWs; they were told that they could use a PCW 
whenever they felt it was appropriate. Health workers were provided with phone numbers of 
study staff and encouraged to call with questions, especially if a negative or invalid RDT 
result was obtained with a PCW during routine use. Study staff returned calls so that there 
was no cost to health workers. 
Assessment of health workers’ performance, interpretation, and use of PCWs. 
After the initial training, health workers’ ability to correctly use PCWs was assessed 
using three approaches at three time points: immediately after training, at the study midpoint 
about 3 months later, and at the end of the study 6 months after training (Figure 2). First, the 
study team used a standardized checklist to observe and score individual participants on PCW 
performance and result interpretation. Health workers had free access to the PCW job aid, 
and any mistakes or questions were addressed after the health worker had completed all steps, 
to avoid biasing the assessment. Second, at the study midpoint and endpoint, each health 
worker was individually presented with panels of reacted RDTs and asked to propose the 
correct actions if they obtained these results with a PCW. Third, the forms completed by 
health workers during their routine work over the study period were retrieved to determine: 1) 
frequency of use of PCWs, 2) results of RDTs tested with PCWs, 3) interpretation of results, 
and 4) any actions taken. 
Assessment of impact of PCW availability on RDT use. 
In Laos, aggregated data on RDT use, results, and treatments prescribed were obtained 
through CMPE from Salavan Province, and from neighboring Sekong Province (control). 
Logbook data, handwritten by health workers, were transferred to the central level for 
computerized data entry. CMPE provided summary data from the 6-month study period and 
from the 3 months preceding it. 
In Uganda, patient-level data were obtained from participating health facilities and 
community workers in Kiboga District and from neighboring Kyankwanzi District (control). 
Logbook data from the study period and the preceding 3 months, handwritten by health 
workers, were transferred to district level for routine reporting and filing and entered into a 
computerized database. Data retrieved included patient age, gender, RDT result (if done), 
diagnosis made, and treatment prescribed. 
Assessment of health workers’ perceptions of PCWs. 
At the end of the 6-month study period, focus group discussions (FGDs) and individual 
semistructured interviews were held to gather qualitative information on health workers’ 
experiences with and perceptions of PCWs. Health workers were purposively selected for 
participation to achieve representation from clinic staff and community workers, 
geographical subregions within the study areas, demographic features, and a range of 
observed abilities to correctly use PCWs. Discussions followed topic guides developed for 
this purpose (Supplemental online material), and were conducted in local languages. 
Data management and statistical analysis. 
Quantitative data were double entered using Microsoft Office Excel 2007 in Laos and 
EpiData (EpiData Association, Odense, Denmark) in Uganda. Stata version 9 (StataCorp, 
College Station, TX), and SPSS version 23 (IBM Corporation) were used for quantitative 
data analysis. Training outcomes were presented as proportions and frequencies. 
Comparisons between groups were made using Pearson’s 2 or Fisher’s exact test, whereas 
changes in performance between assessments were assessed using either McNemar or 
McNemar–Bowker test. Binary logistic regression was used to assess the association between 
age and amount of time the participant had been using RDTs on correctly preparing 
individual PCW steps and interpreting RDT results. Poisson regression was used to assess the 
association between age, facility, and PCW use on the proportions of patients tested by RDT, 
positive by RDT, and RDT-positive patients treated with an antimalarial. Estimated marginal 
means, along with the 95% confidence intervals (CIs), were calculated by the statistical 
software and used to illustrate the proportion of patients tested by RDT, positive by RDT, and 
RDT-positive patients treated with an antimalarial, after adjusting for significant 
confounders. 
For qualitative data, FGD and interview audio files were transcribed into text files and 
translated into English. Analysis was performed with NVIVO QDA Mac Beta 2014 software 
to group key findings into themes and subthemes using content analysis.
21
 Themes that 
emerged from the data were categorized around local concepts of quality control and quality 
assurance. 
RESULTS 
A total of 267 health workers were enrolled in the study in Laos, and 290 in Uganda 
(Table 1). The majority were community workers (72% in Laos, 83% in Uganda), with the 
remainder being facility-based clinical or laboratory staff. 
Assessment of health workers’ performance, interpretation, and use of PCWs. 
Observed performance of PCWs. 
Table 2 summarizes health workers’ performance of PCWs as observed by study staff 
using the standardized checklist. The majority (88% to  99%) of participants correctly 
performed the six key individual PCW steps. Steps that appeared challenging for some 
participants included filling the PCW dropper with the correct amount of water, mixing the 
PCW solution for 120 seconds by counting or using a timer, and transferring a single drop of 
PCW solution to the correct RDT well. Observers’ notes (not shown) indicated that 
apparently poor eyesight, and in some cases, limited finger dexterity, contributed to some 
health workers’ difficulties with the dropper; errors included filling the dropper with water to 
either above or below the indicator mark. Errors in mixing included stirring both for too short 
a time and for too long. Common errors in transferring solution to the RDT included 
struggling or failing to collect a drop of solution from the PCW tube with the RDT transfer 
device, or adding more than one drop of solution; in the latter case, some participants 
mentioned that this was intentional, as they had noticed that adding more solution gave a 
stronger RDT test line. 
When all six key steps in the PCW preparation procedure were considered together, the 
proportion of participants completing all steps correctly ranged from 62% to 93%. When 
errors were made, the majority (67–79%) of participants made only one error in the six steps, 
but the incorrect step varied between participants. In both study areas, the lowest composite 
performance occurred at the study midpoint (Table 2). 
The proportion of health workers who correctly performed all six key PCW steps was not 
influenced by whether the participant was a community worker or clinic staff (P > 0.08), nor 
by how long the participant had been using RDTs in routine patient care (P > 0.15). Overall, 
the proportion of Ugandan participants who correctly performed all key steps was 
significantly lower than the Lao participants (P < 0.05), with the difference increasing over 
time. (Anecdotally, study staff noticed that the Uganda study team tended to be stricter in 
scoring than the Lao study team, so it may not be appropriate to compare the two sites on this 
outcome). Increasing health worker age was associated with an increase in the odds of 
incorrectly filling the PCW dropper in Ugandan participants at all assessments, with odds 
ratios (ORs) varying between 1.03 (95% CI = 1.00–1.07) at the initial assessment and 1.05 
(95% CI = 1.01–1.09) at the final assessment. In Laos, age was only significant at the initial 
assessment where the odds of incorrectly performing this step increased 1.07 (95% CI = 
1.02–1.13)-fold for each year increase in participant age. There was no evidence of an age 
effect in this step during the other assessments (P > 0.8) in Laos. 
Health workers had free access to the job aid while performing the PCW under 
observation (Table 2). In Laos, there was no difference in the frequency of referral to the job 
aid between community workers and facility-based staff (P > 0.1); however, in Uganda, a 
higher proportion of community workers referred to the job aid compared with facility-based 
staff, particularly in the midpoint and study end assessments (P < 0.01). In both countries at 
all assessments, there was no significant association between referral to the job aid during the 
assessment and correctly performing all six key steps (P > 0.2). 
At all three assessment points in both countries,  97% of participants for whom data was 
recorded correctly read the result of the RDT they prepared with a PCW, and  98% gave a 
rational explanation for the result obtained. Errors in reading included confusion between 
positive and negative results or terminology, and failure to read faint lines as positive. Errors 
in explaining the result included both reporting that a positive result indicated a poor-quality 
RDT stock, and reporting that a negative or invalid result indicated a good-quality RDT 
stock. 
Interpretation of panels of reacted RDTs. 
Table 3 shows health workers’ interpretation of reacted RDTs. At the study midpoint, the 
proportion of health workers who gave correct responses for all five RDTs was similar in 
both Laos and Uganda (89%, P > 0.9). At the study end, the proportion declined to 80% in 
Laos, whereas in Uganda, it increased to 93% (P < 0.001). Within each country, the change 
between the midpoint and study end was not significant (P > 0.09). In Laos, 75.3% of 
participants responded correctly for all five RDTs on both occasions, 2.5% made errors on 
both occasions, 14.6% were correct at the midpoint but made at least one error at study end, 
and 7.6% made errors at the midpoint but not at study end. In Uganda, these values were 
83.4%, 1.9%, 5.7%, and 9.1%, respectively. 
Errors were made in responses to positive, negative, and invalid tests. However, most 
participants recognized invalid tests as indicating the need for corrective action (97–99% 
across both sites and evaluation points). A faint positive RDT line presented at the study end 
presented a particular challenge (89% in Laos and 95% in Uganda responded correctly). 
In Laos, there was no difference between the proportion of community workers and clinic 
staff who correctly interpreted all five RDTs (P > 0.08). In contrast, in Uganda at the study 
midpoint, more community workers correctly interpreted all five RDTs correctly (91%) than 
clinic staff (78%; P = 0.022). In both countries, neither age nor time spent using RDTs was 
associated with correct interpretation of RDTs (for Laos, P > 0.2; for Uganda, P > 0.3). There 
was a positive association between participants’ ability to correctly interpret all five RDTs 
and to correctly perform the six key steps in PCW preparation in both countries (analysis not 
shown). 
Use of PCWs during routine clinical work. 
Records on PCW use during routine work over the study period were available from 221 
(83% of total enrolled) to 275 (95%) participants in Laos and Uganda, respectively (Table 4). 
The number of PCWs used was not associated with the length of time a health worker had 
been using RDTs (Spearman’s rank correlation, P > 0.2). 
In Laos, the most common reason given for performing a PCW (481, 64%) was that the 
health worker had received a new stock of RDTs. Performing a PCW because of concerns 
about RDT results obtained with patients was not associated in Laos with type of health 
worker (P = 0.40), but it was somewhat more likely among those who had been using RDTs 
for a longer time (P = 0.06, OR = 1.01 [95% CI = 1.00–1.03]). In Uganda, the primary reason 
given (1,049, 64%) was to check the quality of existing RDT stocks. In Uganda, performing a 
PCW because of concerns about patients’ RDT results was associated with type of health 
worker (P < 0.001, 16% in clinic staff versus 5% in community workers); here this reason 
was somewhat less likely among health workers who had been using RDTs for a longer time 
(P < 0.001, OR = 0.973 [95% CI = 0.958–0.987]). Some Ugandan participants wrote in other 
reasons for performing a PCW at their work site, including practicing or “reminding myself” 
of the PCW procedure, testing RDTs that were near or past their expiry date, or repeating a 
PCW test after an initial negative or invalid result. 
Most records reported a correct action following use of a PCW at the routine work site, 
based on the RDT result obtained. In Laos, 97% of reported actions were correct. In Uganda, 
some participants wrote their action on the record form rather than ticking one of the choices 
on the form. In these cases, it was necessary to interpret the meaning from incomplete 
phrases and then categorize actions as “probably correct” or “probably not correct”; thus, 
94% of actions were categorized as correct, and 99% as “correct or probably correct.” In 
Laos, clinic staff were slightly more likely than community workers to record a corrective 
action (99% versus 96%, P = 0.013), whereas in Uganda, there was no difference (P > 0.9). 
There was no association between reporting a correct or probably correct action and the 
length of time a health worker had been using RDTs in either country (P > 0.5). Reported 
actions were more often correct if the RDT result obtained with a PCW was positive than if 
the result was negative or invalid. 
Impact of PCW availability on RDT use. 
In Laos, when aggregated data from clinic staff were compared between the PCW and 
control provinces, there were significant differences in the proportion of patients receiving an 
RDT in Salavan versus Sekong (P < 0.001), and also between patient age groups within each 
province (P < 0.001; Table 5). However, there was no difference in the rate of RDT use 
between the pre-PCW period (December 2012–March 2013) and the PCW period (April–
November 2013) in either province (P > 0.6). In Salavan, the relative risk of receiving 
antimalarial treatment in a health facility, adjusted for the number of positive RDTs, was 1.04 
(95% CI = 1.03–1.06) times higher after PCW introduction (April–November) compared 
with before PCW introduction (December–March) (P < 0.001; Table 5). No change in 
treatment rates by clinic staff were detected in Sekong between these same periods (P = 
0.14). Data for community workers in Salavan and Sekong list only patients who were tested 
with RDTs (i.e., the proportion tested was 100%) and report that 100% of RDT-positive 
patients were treated with artemisinin-based combination therapy; no further analysis is 
possible. 
In Uganda, individual patient data were compared between the PCW and control districts, 
stratified for management by clinic staff and community workers. Clinic staff performed a 
total of 60,144 RDTs for 87,893 patients. The proportion of patients tested was significantly 
higher in the control district (Kyankwanzi) than in Kiboga, and was also significantly higher 
in the pre-PCW period in both districts (Table 6). In the control district, the odds of receiving 
antimalarial treatment of positive RDT results increased significantly in the second part of the 
study (OR = 1.27, 95% CI = 1.02–1.58, P = 0.033). In Kiboga, none of the factors tested was 
a significant predictor of antimalarial treatment of RDT-positive cases (P > 0.2) with 96.7% 
receiving treatment. A lower proportion of RDT-negative patients received antimalarial 
treatment in Kiboga District than in the control area. In Kiboga, after introduction of PCWs, 
antimalarial treatment of RDT-negatives increased for young children but decreased for older 
patients; whereas in the control district, treatment of negatives increased for all age groups 
over the same time period. 
Records for 39,882 patients seen by community health workers in Uganda were analyzed 
(Table 7). The odds of conducting an RDT were 1.61 (95% CI = 1.49–1.74) times higher for 
the post-PCW period compared with the pre-PCW period in both districts. Patients with 
positive RDT results had twice the odds of receiving antimalarial treatment in Kiboga 
compared with Kyankwanzi (OR = 2.20, 95% CI = 1.49–3.27), although both districts treated 
over 99% of RDT-positive cases with antimalarials (Table 7). In Kiboga, the proportion of 
RDT-negative patients treated with an antimalarial decreased from 35.4% before PCW 
introduction to 23.3% afterward. In Kyankwanzi, the proportion increased from 20.9% pre-
PCW to 60.3% over the same time period. 
Qualitative findings on health workers’ perceptions of PCWs. 
In Laos, 84 participants (60% community workers) took part in 11 semistructured 
interviews and 11 FGDs. In Uganda, 119 participants (76% community workers) participated 
in 29 interviews and 11 FGDs. A more extensive analysis of qualitative data will be reported 
elsewhere; a summary of key findings is presented herein. 
Most health workers reported that difficulties in performing the PCWs were generally 
minor and became easier with training and experience. Several noted the challenge posed by 
the appearance of faint—rather than clearly visible—RDT test lines with PCW use (Box 1, 
Quote 1 [Q1]). 
In general, PCWs were discussed by health workers as a way to confirm RDT quality and 
restore confidence in RDT results in some situations where doubts existed. For example, 
when health workers encountered a discrepancy between their own clinical impression (that a 
patient had malaria) and a negative RDT result, PCW use was reported to help resolve the 
uncertainty (Q2 and Q3). Some health workers mentioned their use of PCWs to patients as a 
way of convincing them that RDT results were reliable (Q4); but more often health workers 
did not mention PCWs to patients as they believed such information was too technical for 
patients to understand, or was relevant only for health workers (Q5 and Q6). 
In both Laos and Uganda, among both clinic staff and community workers, one of the 
most frequently mentioned reasons for health workers to doubt RDT results was obtaining 
“too many” consecutive similar results when testing patients, especially consecutive negative 
results (Q7). Previously, typical reactions to this concern might have been either to repeat a 
patient’s test to confirm the result (Q8), or to disregard a negative result and treat empirically 
with antimalarials. PCWs appeared to have some capacity to restore trust for health workers 
faced with serial negative results (Q9). 
Before PCW introduction most health workers recognized that RDTs could be of poor 
quality or faulty. However, for some, the introduction of PCWs appeared to confirm this 
possibility (Q10). Similarly, health workers had previously been trained to check RDTs’ 
expiration date and desiccant packet as a means of quality control; whereas PCWs introduced 
a new quality-control option that needed to be translated into understanding and practice 
(Q11). However, the availability of multiple quality-control indicators also led some health 
workers to experiment with expired RDTs (Q12). Finally, some participants questioned 
whether PCWs could also be of poor quality (Q13–15). 
DISCUSSION 
PCWs have been developed as a point-of-care quality-control tool to monitor the validity 
of malaria RDTs. This study introduced PCWs for use by front-line health workers in Laos 
and Uganda. In both settings, after a half-day training, most participating clinic staff and 
community health workers were able to correctly perform PCWs and interpret results, and to 
maintain these skills over the 6-month study duration. When PCWs were provided at health-
care sites for routine use, most participants recorded correct use of PCWs and appropriate 
actions based on results. There were both quantitative and qualitative evidences in some 
settings that PCWs improved health workers’ confidence in RDT results for patient care. 
For PCW use to be effective, users must correctly perform PCW steps and interpret 
RDTs, and take the appropriate action based on RDT results. PCW steps that appeared most 
challenging included obtaining and transferring the correct volumes of water and PCW 
solution, and stirring the solution for the recommended length of time. Similar difficulties 
with transferring small, precise volumes have been reported in RDT training efforts, 
especially among lower-level health workers.
11,22,23
 Significant errors in volume transfer and 
stirring could lead to too little antigen reaching the RDT, which may result in a “false-
negative” result and a false impression that the RDT is defective. Pending any simplification 
of the PCW format, careful training and supervision may reduce this risk. PCW validation 
and stability studies are ongoing, and final technical specifications will be reported 
elsewhere. 
Anecdotally, study team observers noted that poor eyesight appeared to contribute to 
some participants’ difficulties preparing PCWs; visual acuity was not assessed 
systematically, but health worker age (which may be a proxy in some cases) was associated 
with incorrectly filling the PCW dropper particularly in Uganda. Poor vision may also 
influence health workers’ interpretation of RDT results, especially in the case of faint test 
lines.
24,25
 The amount of antigen in a PCW is intended to differentiate between a valid RDT, 
and one that cannot detect the lower limits of most clinically significant parasitemia (200 
parasites/µL)
20
; therefore, PCW solution typically produces a faint RDT test line on a 
working RDT. Both quantitative and qualitative data indicate that some study participants 
were uncertain of how to interpret faint test lines, although PCW training had stated that a 
line of any intensity should be considered positive. Indeed, some health workers intentionally 
applied more than the recommended volume of PCW solution to achieve a stronger test line. 
In general, the few health workers who found one aspect of PCWs challenging (e.g., 
preparation steps) also made errors with others (e.g., interpretation). Therefore, future PCW 
implementation programs could plan to identify health workers who may benefit from extra 
training assistance. The training materials and pictorial guide designed for this study 
appeared appropriate for the participating front-line health workers. No significant patterns 
were identified between PCW performance and length of experience with RDTs. Also, no 
substantial differences between clinic staff and community workers were seen in ability to 
correctly perform, interpret and use PCWs. In many settings, community health workers 
(village health volunteers) are tasked with managing malaria with or without RDTs.
26–28
 This 
study provides reassurance that PCWs may also be integrated into such programs. 
During the study, all negative or invalid RDT results obtained with PCWs were 
immediately followed up by telephone with the reporting health worker. Study staff verbally 
assisted the health worker to repeat the PCW assessment with another RDT from the same 
stock. In all cases, the repeat test result was positive; there were no confirmed cases of poor-
quality RDT stocks identified during the study. In other settings, where poor-quality RDTs 
may be more common, extra attention may be required to ensure that functional reporting and 
response systems are in place to handle health workers’ reports in a timely way. 
Where data are available to assess the effect of PCWs on RDT use and patient 
management, these appear to be neutral or, in some cases, possibly beneficial. In Laos, 
antimalarial treatment of RDT-positive patients rose after PCW introduction, but it is unclear 
whether this effect was due to PCWs or to other factors. In Uganda, after PCW introduction, 
use of RDTs dropped among clinic staff in both the PCW and control area, whereas it rose 
among community workers in both areas; no clear explanation (e.g., fluctuations in RDT 
supply) for these differences was identified. There were no substantial changes in 
antimalarial treatment of RDT-positives in Uganda. However, after PCW introduction, 
antimalarial treatment of RDT-negative patients declined significantly for patients older than 
5 years managed by clinic staff, and for all patients seen by community workers; this 
occurred in the face of large increases over the same time period in the control district (and 
for young children managed by clinic staff in the PCW district). Coupled with qualitative 
data indicating that PCWs boosted many health workers’ confidence in RDT results, these 
findings suggest that PCWs may help to address the persistent problem of unnecessary 
antimalarial treatment of test-negative patients.
29,30
 
At the study end, health workers were asked about their recommendations for future 
implementation of PCWs (data not shown). Around three-quarters of Lao health workers and 
two-thirds in Uganda suggested that PCWs should be packaged separate from RDTs to avoid 
waste and to avoid the risk of exposing both RDTs and PCWs to adverse transport and 
storage conditions. Health workers who favored packaging PCWs and RDTs together cited 
convenience as a rationale. Most participants recommended that PCWs should be 
implemented alongside clear guidelines for when to use them (rather than leaving health 
workers to design their own schedules). 
This study has several limitations. Health workers knew that they were participating in 
research, so the Hawthorne effect may have influenced their PCW performance under 
observation as well as records kept during routine work. Keeping written records appeared to 
be challenging for some study participants, especially in Laos where some records with 
missing data were excluded from analysis. This observation reflects the challenges of 
conducting research among front-line health workers in malaria-endemic areas (and also 
highlights one of the challenges encountered when health-care systems must rely on staff 
with limited education). More PCWs were used per health worker in Uganda than in Laos, 
perhaps at least in part because the RDTs in the Uganda study area were more freely 
available. Patient-level data on RDT use and antimalarial prescribing was only available in 
Uganda, so the effects seen there could not be compared with data from Laos. 
The need for malaria RDT quality-control strategies, appropriate for routine health-care 
settings in endemic areas, is well recognized.
10–13
 Alternatives such as microscopy and 
molecular tools as reference tests use different biological parameters, do not provide real-
time information and are generally not feasible for most programs. Some RDT manufacturers 
sell positive controls as a separate catalogue item, but these require a cold chain, are product 
specific, and some are not for single use. Alternatively, researchers have evaluated dried 
blood containing cultured Plasmodium falciparum parasites at specific densities as a positive 
control for RDTs, but this approach does not generate consistently reproducible antigen 
concentrations; in addition, the need for cultured parasites, potential for degradation under 
field conditions, and multiple rehydration steps limit their use.
14,31
 If technical specifications 
are met, including stability under typical storage conditions,
15
 PCWs based on dried 
recombinant antigen, such as the prototype introduced in this study, appear best suited for 
wide-scale implementation. 
CONCLUSIONS 
This is the first study to introduce PCWs for malaria RDTs for routine use by front-line 
health workers in endemic areas. Over the 6-month study period, health workers were able to 
correctly prepare and interpret PCW results to identify and report poor-quality RDTs. Results 
suggest that PCWs may improve health workers’ confidence in RDT results, and reduce 
antimalarial overtreatment of RDT-negative patients. Data collected are intended to guide 
eventual implementation strategies for PCWs that meet technical specifications. Future work 
should refine these strategies for various contexts, and evaluate the longer term impact of 
PCWs on health worker behaviors, patient management, and cost-effectiveness of RDT use. 
Lessons learned from malaria RDT and PCW implementation may be valuable in introducing 
other point-of-care diagnostic and quality-control tools. 
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FIGURE 1. Prototype positive control well (PCW) for malaria rapid diagnostic tests. This figure appears in color 
at www.ajtmh.org. 
FIGURE 2. Study flow diagram. Study activities and data collection: In each of the two study areas, one province 
in Lao People’s Democratic Republic and one district in Uganda, a target sample of approximately 300 health 
workers was recruited to participate in the study. Participants were trained in positive control well (PCW) use, 
and supplies of PCWs were left at each work site. Data collection continued for 6 months after the introduction 
of PCWs. Routine clinical and rapid diagnostic test (RDT) use data from a neighboring area in each country, 
without PCWs, were retrieved as a comparison. 
TABLE 1 
Participating health workers: enrolment population and descriptive data 
Feature 
Lao People’s 
Democratic Republic 
Uganda 
Number (%) unless 
Number (%) unless 
otherwise indicated 
otherwise indicated 
No. of participants enrolled 267 290 
Age in years: median, interquartile range, range 36, 28–45, 17–73 40, 32–47, 22–69 
Female gender 57 (21) 151 (52) 
Male gender 210 (79) 139 (48) 
Professional category 
 Community workers 192 (72) 240 (83) 
 Clinic staff 75 (28) 50 (17) 
Highest educational level achieved* 
 Any primary school 118 (45) 125 †(43) 
 Any secondary school 125 (48) 128 (44) 
 Laos: Diploma/Uganda: Tertiary or University 20 (8) 37 (13) 
Formally trained in RDT use 237/265 (89) 277 (96) 
If trained, approximate no. of months ago‡: median, 
interquartile range, range 
24, 12–48, 1–120 33, 24–34, 1–60 
Has used RDTs in routine patient care 251/264 (95) 288 (99) 
If RDTs used, approximate no. of months used§: median, 
interquartile range, range 
36, 15–48, 1–120 32, 24–34, 1–60 
Participation—no. of health workers who attended the 
three study assessments‖ 
  
 All: 1, 2, and 3 172 (64) 263 (91) 
 1 only 26 (10) 10 (3) 
 1 and 2 only 20 (7) 8 (3) 
 1 and 3 only 49 (18) 9 (3) 
RDT = rapid diagnostic test. 
* Data missing for four participants in Laos. 
† Includes three who reported no formal education. 
‡ Data missing for 56 participants in Laos; for eight in Uganda. 
§ Data missing for 50 participants in Laos; for 11 in Uganda. 
‖ In Laos, heavy flooding in the study area affected travel conditions and health worker attendance. 
TABLE 2 
Positive control well performance checklist 
 Lao People’s Democratic Republic 
Number (%) 
Uganda 
Number (%) 
 Study start (N = 
267) 
Midpoint (N = 
192) 
Study end (N = 
221) 
Study start (N = 
290) 
Midpoint (N = 
271) 
Study end (N = 
272) 
Looked at job aid  3 times while performing PCW 64/266 (24) 68 (35) 63/220 (29) 252/288 (88) 199/270 (74) 144/268 (54) 
Looked at job aid 1 and 2 times while performing PCW 55/266 (21) 68 (35) 67/220 (30) 20/288 (7) 58/270 (21) 81/268 (30) 
Did not look at job aid while performing PCW 147/266 (55) 56 (29) 90/220 (41) 16/288 (6) 13/270 (5) 43/268 (16) 
Six key steps in PCW procedure Number (%) of health workers performing PCW procedure step correctly 
 Fill PCW dropper with water to mark 256 (96) 180 (94) 214/220 (97) 255 (88) 223 (82) 240 (88) 
 Empty water into PCW tube 262 (98) 183 (95) 218 (99) 286 (99) 262 (97) 252 (93) 
 Mix solution for 120 seconds 260 (97) 189 (98) 214 (97) 276 (95) 235 (87) 249 (92) 
 Transfer one drop PCW solution to correct RDT well 257 (96) 176 (92) 216 (98) 282/289 (98) 245 (90) 259 (95) 
 Put correct no. of buffer drops into correct well 261/266 (98) 187 (97) 217/220 (99) 278 (96) 260 (96) 258 (95) 
 Wait correct length of time before reading RDT result 264/265 (99.6) 189 (98) 217 (98) 282/289 (98) 267/270 (99) 258/270 (96) 
All PCW preparation steps completed correctly 235/264 (89) 158 (82) 204/219 (93) 227/285 (80) 166/266 (62) 188/270 (70) 
Read RDT result correctly 248/252 (98) 190 (99) 213/219 (97) 282/287 (98) 264/270 (98) 264/267 (99) 
Give a correct/rational explanation for RDT result 253/256 (99) 190/191 (99) 214/219 (98) 281/284 (99) 265 (98) 261/266 (98) 
PCW = positive control well; RDT = rapid diagnostic test. Health worker performance of PCW with RDT, observed by study staff, immediately after training at start of study, at study 
midpoint 3 months after training, and at study end 6 months after training. 
* Some observations missing, as indicated by insertion of denominators. 
TABLE 3 
PCW study participants’ interpretation of reacted RDTs, in response to question: “What would you do if you got this result while using a PCW to check the RDT stock at your usual post 
of work?”* 
Study midpoint Study end 
True result of RDT Correct proposed action† True result of RDT Correct proposed action† 
 Laos (N = 188) Uganda (N = 275)  Laos (N = 216) Uganda (N = 277) 
RDT 1 (positive) 181 (96) 266 (97) RDT 1 (positive) 210/215 (98) 276 (99.6) 
RDT 2 (negative) 185/187 (99) 263 (96) RDT 2 (positive; faint line) 191/214 (89) 262 (95) 
RDT 3 (invalid) 185/87 (99) 266 (97) RDT 3 (negative) 198/214 (93) 273 (99) 
RDT 4 (negative) 183 (97) 264 (96) RDT 4 (invalid) 208/211 (99) 274 (99) 
RDT 5 (positive) 171 (91) 269 (98) RDT 5 (negative) 199 (92) 273 (99) 
Composite: all five responses 
correct 
167/187 (89) 246 (89) Composite: all five responses 
correct 
166/208 (80) 257 (93) 
PCW = positive control wells; RDT = rapid diagnostic test. 
* Some observations missing, as indicated by insertion of denominators. 
† The correct action in response positive RDT results included continuing to use the stock of RDTs in routine patient care. The correct actions in response to negative or invalid RDT 
results included repeating the PCW assessment with a second RDT from the same batch, calling the study team or supervisor for advice, or returning the stock of RDTs to a supervisor for 
replacement. 
TABLE 4 
Records of positive control well use kept by health workers at their work sites over 6-month study period 
Feature 
Lao People’s 
Democratic Republic* 
Number (%) 
Uganda 
Number (%) 
No. of health workers who brought PCW use records 221 (83) 275 (95) 
Total no. of PCW use records received 762 1685 
No. of PCWs used per reporting clinic staff: median, 
interquartile range, range 
3, 2–5, 1–12 7, 5–12, 1–28 
No. of PCWs used per reporting community worker: 
median, interquartile range, range 
3, 2–4, 1–7 5, 4–7, 1–20 
Recorded reason for performing a PCW (reasons are not exclusive) 
 “I received a new stock of RDTs” 481/747 (64) 4,83/1,645 (29) 
 “I wanted to check the quality of my RDTs” 239 (32) 1,049 (64) 
 “I have been getting many negative RDT results with 
patients” 
16 (2) 74 (5) 
 “I’m not sure about the RDT results I am getting” 11 (1) 51 (3) 
 Other reasons 0 109 (7) 
RDT result with PCW 
 Positive 711/738 (96) 1,510/1659 (91) 
 Negative† 24 (3) 142 (9) 
 Invalid† 3 (0.4) 7 (0.4) 
Recorded action in response to PCW result 
 Continue using RDT stock with patients 688/723 (95) 1,426/1,651 (86) 
 Repeat PCW quality check with another RDT 32 (4) 209 (13) 
 Stop using RDT stock and call supervisor and/or study 
team 
2 (0.3) 31 (2) 
“Correct” action based on recorded RDT result 685/709 (97) 1,533/1,626 (94) 
“Probably correct” action* — 77 (5) 
“Correct” or “probably correct” action* — 1610 (99) 
“Incorrect” action recorded based on recorded RDT result 24/709 (3) 11 (1) 
“Correct” action if RDT recorded as positive 667/683 (98) 1,411/1,488 (95) 
“Incorrect” action if RDT recorded as positive 16 (2) 0 
“Correct” action if RDT recorded as negative or invalid 18/26 (69) 122/138 (88) 
“Incorrect” action if RDT recorded as negative or invalid 8 (31) 11 (8) 
PCW = positive control wells; RDT = rapid diagnostic test. 
* Many Ugandan participants wrote their action on the record form rather than using the tick boxes. In some 
cases, this necessitated interpreting the intended action from incomplete phrases, which resulted in 
categorization as “probably correct” or “probably not correct.” 
† All negative or invalid RDT results that were reported to study staff were followed up immediately by 
telephone. In all cases, when the health worker was verbally assisted to repeat the assessment with the correct 
procedure using a second RDT from her/his stock, the result was positive. There were no confirmed cases of 
poor-quality RDT stocks identified during the study. 
TABLE 5 
EMMs for RDT, results, and antimalarial treatment in Lao People’s Democratic Republic health facilities with 
and without PCWs* 
Province 
Patient age 
(years) 
EMM for proportion of 
patients receiving RDT 
(95% CI*) 
EMM for proportion of 
patients RDT-positive 
(95% CI*) 
EMM for proportion of RDT-positive 
patients receiving antimalarial 
treatment (95% CI) 
Sekong 
(control) 
0–5 0.331 (0.288–0.380) 0.184 (0.115–0.296) 
0.972 (0.955–0.988) 
> 5 0.420 (0.384–0.460) 0.147 (0.119–0.181) 
Salavan 
(PCW) 
0–5 0.397 (0.352–0.447) 0.184 (0.115–0.296) Pre-PCW: 0.934 (0.922–0.947) 
> 5 0.504 (0.480–0.529) 0.308 (0.286–0.332) Post-PCW: 0.974 (0.965–0.982) 
CI = confidence interval; EMM = estimated marginal mean; PCW = positive control wells; RDT = rapid 
diagnostic test. 
* EMMs are presented individually for groups where significant differences were detected (P < 0.05), and are 
merged across categories when no significant difference between categories was detected. 
TABLE 6 
EMMs for RDT, results, and antimalarial treatment in Uganda health facilities with and without PCWs* 
District Period 
Patient 
age 
(years) 
EMM for 
proportion of 
patients receiving 
RDT (95% CI*) 
EMM for 
proportion of 
patients RDT-
positive (95% 
CI*) 
EMM for 
proportion of 
RDT-positive 
patients 
receiving 
antimalarial 
treatment (95% 
CI*) 
EMM for proportion 
of RDT-negative 
patients receiving 
antimalarial 
treatment (95% CI*) 
Kyankwanzi 
(control) 
Pre-
PCW 
< 5 0.858 (0.850–0.865) 0–5 years: 
0.403 (0.394–
0.412) > 5 
years: 0.351 
(0.345–0.357) 
0.975 (0.971–
0.978) 
0.302 (0.289–0.316) 
 5 0.830 (0.824–0.836) 0.196 (0.188–0.205) 
Post-
PCW 
< 5 0.725 (0.715–0.735) 0.980 (0.977–
0.983) 
0.431 (0.414–0.449) 
 5 0.734 (0.728–0.740) 0.340 (0.331–0.350) 
Kiboga 
(PCW) 
Pre-
PCW 
< 5 0.650 (0.634–0.665) 0.470 (0.458–
0.482) 0.967 (0.962–
0.971) 
0.024 (0.017–0.034) 
 5 0.546 (0.535–0.557) 0.047 (0.039–0.056) 
Post-
PCW 
< 5 0.545 (0.531–0.559) 0.571 (0.562–
0.579) 
0.056 (0.044–0.072) 
 5 0.525 (0.518–0.533) 0.019 (0.015–0.023) 
CI = confidence interval; EMM = estimated marginal mean; PCW = positive control wells; RDT = rapid 
diagnostic test. 
* EMMs are presented individually for groups where significant differences were detected (P < 0.05), and are 
merged across categories when no significant difference between categories was detected. 
TABLE 7 
EMMs for RDT, results, and antimalarial treatment in Uganda community work stations with and without 
PCWs* 
District Period 
Patient 
age 
(years) 
EMM for 
proportion of 
patients receiving 
RDT (95% CI*) 
EMM for proportion 
of patients RDT 
positive (95% CI*) 
EMM for 
proportion of 
RDT-positive 
patients receiving 
antimalarial 
treatment (95% 
CI*) 
EMM for 
proportion of 
RDT-negative 
patients receiving 
antimalarial 
treatment (95% 
CI*) 
Kyankwanzi 
(control) 
Pre-
PCW 
< 5 0.869 (0.861–
0.877) 
0.749 (0.738–0.759) 
0.996 (0.995–
0.997) 
0.209 (0.176–
0.246)  5 0.616 (0.516–0.707) 
Post-
PCW 
< 5 0.915 (0.911–
0.919) 
0.775 (0.768–0.781) 0.603 (0.564–
0.642)  5 0.649 (0.552–0.735) 
Kiboga 
(PCW) 
Pre-
PCW 
< 5 0.843 (0.832–
0.853) 
0.691 (0.677–0.706) 
0.992 (0.989–
0.994) 
0.354 (0.281–
0.434)  5 0.546 (0.444–0.645) 
Post-
PCW 
< 5 0.896 (0.890–
0.902) 
0.721 (0.711–0.730) 0.232 (0.201–
0.266)  5 0.582 (0.480–0.677) 
CI = confidence interval; EMM = estimated marginal mean; PCW = positive control wells; RDT = rapid 
diagnostic test. 
* EMMs are presented individually for groups where significant differences were detected (P < 0.05), and are 
merged across categories when no significant difference between categories was detected. 
BOX 1 
Representative quotes from health worker participants in focus group discussions and semistructured interviews 
Quote 1: Q: Which steps of PCWs are most difficult? A1: It’s difficult only when we stir it, sometimes we 
miscounted. A2: Sometimes the line was faded, which makes it difficult to read. Q: Was it difficult to read? 
A1: Yes, the line color was faded but it was readable. A2: The line was not clear, I didn’t know what to say. 
08-CW-FGD/Laos 
Quote 2: There are times when you get patients that clinically look sick but when you test the RDT shows 
negative results, so you begin doubting your results and then use the PCW, if it gives you positive results then 
you get sure that they are still good. 03-CS-FGD/Uganda 
Quote 3: Before PCWs came I did not trust them because they could bring a convulsing child and the test 
turns out to be negative. In that situation you write a referral form while questioning the RDT quality. 
Sometimes you find that the child has high fever and you expect it to be malaria but you find it negative. So at 
first we had doubts … until PCWs were brought, so we are now sure of what we do. 08-CW-FGD/Uganda 
Quote 4: Whenever they doubt our RDTs we tell them that we have something, which helps us to check the 
quality of RDTs if they are still good. So after checking them if they give us negative results then that means 
you probably have cough, flu or something else, not malaria, so that is what we should treat because it’s the 
cause of the fever. 02-CS-FGD/Uganda 
Quote 5: When you begin doubting you don’t tell the patient but you perform a PCW and when you get 
positive you know that your RDTs are good. 04-CS-FGD/Uganda 
Quote 6: First of all the PCW has removed that doubt from the health worker so the only task is to convince 
the patient to accept the negative result. 03-CS-FGD/Uganda 
Quote 7: When I get numerous consecutive negatives and also when I get many positives still I lose trust in 
[RDT results]. 08-CS-SSI/Uganda 
Quote 8: I had to do the blood testing twice. If the results were still negative then people were not infected 
with malaria, because there are many diseases that have signs and symptoms like malaria. 05-CS-FGD/Laos 
Quote 9: I used to doubt the negative test results when there were many negative results because previously 
we didn’t have positive control wells. 05-CS-FGD/Laos 
Quote 10: Before PCWs came we used to treat without caring about whether RDTs are good or not, they 
could show constant results e.g. negative or positive yet they might have been wrong. But when PCWs came, 
I now feel confident of what I am using. 11-CW-FGD/Uganda 
Quote 11: A1: No, we can test the RDT by shaking the desiccant and also the expiry date. A2: But that does 
not test the quality, it only shows that it is in normal working condition, but doesn’t show the quality. 04-CS-
FGD/Uganda 
Quote 12: Now that beats my understanding because if these RDTs have expired and then you test them with 
the PCW and get positive results why don’t we use them? [laughter from other participants] Because they 
say PCWs check the quality of RDTs, so then if they are saying that the quality is good, why don’t we then 
use them? 04-CS-FGD/Uganda 
Quote 13: Q: If PCW performance shows a negative or bad RDT, do you trust this result? A1: No, I don’t 
trust [it]. There might be some mistakes in the PCW performance. [laughter from other participants] A2: I 
think that the RDT box might be of bad quality. A3: If [the RDTs] are kept in a good place and are not 
expired, I probably think that the PCW kit is bad. 06-CW-FGD/Laos 
Quote 14: Q: If we are certain of the two performances, why do you think the results are different? A1: I have 
to think of PCW, it might have deteriorated. Q: How can a PCW deteriorate? A1: PCWs [also] have a shelf 
life. A2: It might be due to the water used, it is very difficult to find clean water. 05-CS-FGD/Laos 
Quote 15: A1: But I have a question: How do you test the PCWs to identify their quality? A2: That one has 
not yet come. [laughter from other participants] 04-CS-FGD/Uganda 
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Figure 2
Study activities and data collection: In each of the two study areas, one province in Lao PDR and one 
district in Uganda, a target sample of approximately 300 health workers was recruited to participate in 
the study. Participants were trained in PCW use, and supplies of PCWs were left at each work site. Data 
collection continued for six months following the introduction of PCWs. Routine clinical and RDT use 
data from a neighbouring area in each country, without PCWs, were retrieved as a comparison.
Study completion and collection of final data:
• Presentation of different coded panel of reacted
RDTs to assess health workers’ ability to 
interpret RDTs prepared with PCWs
• Standardized assessment of PCW performance 
by health workers
• Focus group discussions and individual 
interviews to assess health worker perceptions 
of PCWs
Study enrollment:
• Introduction of PCWs to participating health 
workers, using standardized training materials
• Standardized assessment of PCW performance 
by health workers
Study midpoint:
• Presentation of coded panel of reacted RDTs to 
assess health workers’ ability to interpret RDTs 
prepared with PCWs
• Standardized assessment of PCW performance 
by health workers
 
Retrieval of 6 months routine clinical 
data from neighbouring area as 
comparison 
No introduction of PCWs in 
neighbouring province or district; 
routine RDT use
6 months’ collection of data on 
PCW and RDT use          
among all participants
